In summary, higher level of HIF-1 expression might indicate a poorer prognosis in patients with HCC, and HIF-1 could be used as a novel useful biomarker for the prediction of prognosis of HCC patients. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.